Eli Lilly’s Groundbreaking Alzheimer’s Drug, Kisunla, Gains FDA Approval

In a significant stride for medical science and the millions of Americans affected by Alzheimer’s disease, Eli Lilly & Co. has received FDA approval for its new drug, Kisunla. This approval marks Kisunla as the second drug capable of slowing the progression of this debilitating condition, offering new hope to patients and their families. A […]